Innoviva Strategic Opportunities LLC

Innoviva Strategic Opportunities LLC insider trades: Entasis Therapeutics Holdings (ETTX) stock purchases

Entasis Therapeutics Holdings Last trade Jul 11, 2022 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2021
2
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Innoviva Strategic Opportunities LLC reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 11, 2022ETTX↑ Buy$42.4M
Mar 31, 2022ARMP↑ Buy$26.9M
Feb 9, 2022ARMP↑ Buy$18.1M
Oct 29, 2021ARMP↑ Buy$4.0M
Jun 11, 2021ETTX↑ Buy$12.5M
May 3, 2021ETTX↑ Buy$7.5M
Mar 17, 2021ARMP↑ Buy$13.9M
Jan 26, 2021ARMP↑ Buy$6.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Innoviva Strategic Opportunities LLC's insider trades

Innoviva Strategic Opportunities LLC is an insider at Entasis Therapeutics Holdings (ETTX). Since Jan 26, 2021, it has reported 8 open-market purchases worth $131.4M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.